source
- Experts suggest new safety framework to boost predictability of CNS toxicity assessmentsA recent paper outlines a safety framework intended to make central nervous system (CNS) toxicity predictions more reliable during drug development. The authors argue that new approach methodologi…
- Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical PracticeSanam Loghavi, MD, discusses updated WHO diagnostic criteria for acute myeloid leukemia and its significance for diagnoses and treatment selection.onclive · 3mo ago↗ source
- FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML